A novel high-throughput screening system identifies a small molecule repressive for matrix metalloproteinase-9 expression

Rajesh R. Nair, Hector Avila, Xujun Ma, Zhengxin Wang, Michelle Lennartz, Bryant G. Darnay, Douglas D. Boyd, Chunhong Yan

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Aberrant gene expression is one of the driving forces for cancer progression and is considered an ideal target for chemical intervention. Although emerging bioluminescence reporter systems allow high-throughput searches for small molecules regulatory for gene expression, frequent silencing of reporter genes by epigenetic mechanisms hinders wide application of this drug discovery strategy. Here we report a novel system that directs the integration of a promoter-reporter construct to an open chromosomal location by Flp-mediated homologous recombination, thereby overcoming reporter-gene silencing. Using this system, we have screened more than 8000 compounds in the DIVERSet chemical library for repressors of a matrix metalloproteinase-9 (MMP-9) promoter and identified 5-methyl-2-(4-methylphenyl)-1H-benzimidazole (MPBD) inhibitory for MMP-9 gene expression. Consistent with this effect, MPBD inhibits MMP-9-dependent invasion of UMSCC-1 oral cancer cells, preosteoclast migration, and receptor activator of nuclear factor-κB ligand-induced osteoclast activity over concentration ranges that repressed MMP-9 expression. Mechanistic studies indicated that MPBD antagonizes AP-1 function by inhibiting its transactivation activity. We conclude that the Flp-mediated homologous recombination system to direct reporter integration into open chromatin regions represents a novel strategy allowing for the development of high-throughput systems screening for lead compounds targeting aberrant gene expression in cancer.

Original languageEnglish (US)
Pages (from-to)919-929
Number of pages11
JournalMolecular Pharmacology
Volume73
Issue number3
DOIs
StatePublished - Mar 1 2008
Externally publishedYes

Fingerprint

Matrix Metalloproteinase 9
Gene Expression
Homologous Recombination
Reporter Genes
Small Molecule Libraries
Systems Integration
Mouth Neoplasms
Transcription Factor AP-1
Gene Silencing
Osteoclasts
Drug Discovery
Regulator Genes
Cytoplasmic and Nuclear Receptors
Epigenomics
Transcriptional Activation
Chromatin
Cell Movement
Neoplasms
Ligands
benzimidazole

ASJC Scopus subject areas

  • Pharmacology

Cite this

A novel high-throughput screening system identifies a small molecule repressive for matrix metalloproteinase-9 expression. / Nair, Rajesh R.; Avila, Hector; Ma, Xujun; Wang, Zhengxin; Lennartz, Michelle; Darnay, Bryant G.; Boyd, Douglas D.; Yan, Chunhong.

In: Molecular Pharmacology, Vol. 73, No. 3, 01.03.2008, p. 919-929.

Research output: Contribution to journalArticle

Nair, Rajesh R. ; Avila, Hector ; Ma, Xujun ; Wang, Zhengxin ; Lennartz, Michelle ; Darnay, Bryant G. ; Boyd, Douglas D. ; Yan, Chunhong. / A novel high-throughput screening system identifies a small molecule repressive for matrix metalloproteinase-9 expression. In: Molecular Pharmacology. 2008 ; Vol. 73, No. 3. pp. 919-929.
@article{9e1fdf5a8d2d438aadb87d540946f630,
title = "A novel high-throughput screening system identifies a small molecule repressive for matrix metalloproteinase-9 expression",
abstract = "Aberrant gene expression is one of the driving forces for cancer progression and is considered an ideal target for chemical intervention. Although emerging bioluminescence reporter systems allow high-throughput searches for small molecules regulatory for gene expression, frequent silencing of reporter genes by epigenetic mechanisms hinders wide application of this drug discovery strategy. Here we report a novel system that directs the integration of a promoter-reporter construct to an open chromosomal location by Flp-mediated homologous recombination, thereby overcoming reporter-gene silencing. Using this system, we have screened more than 8000 compounds in the DIVERSet chemical library for repressors of a matrix metalloproteinase-9 (MMP-9) promoter and identified 5-methyl-2-(4-methylphenyl)-1H-benzimidazole (MPBD) inhibitory for MMP-9 gene expression. Consistent with this effect, MPBD inhibits MMP-9-dependent invasion of UMSCC-1 oral cancer cells, preosteoclast migration, and receptor activator of nuclear factor-κB ligand-induced osteoclast activity over concentration ranges that repressed MMP-9 expression. Mechanistic studies indicated that MPBD antagonizes AP-1 function by inhibiting its transactivation activity. We conclude that the Flp-mediated homologous recombination system to direct reporter integration into open chromatin regions represents a novel strategy allowing for the development of high-throughput systems screening for lead compounds targeting aberrant gene expression in cancer.",
author = "Nair, {Rajesh R.} and Hector Avila and Xujun Ma and Zhengxin Wang and Michelle Lennartz and Darnay, {Bryant G.} and Boyd, {Douglas D.} and Chunhong Yan",
year = "2008",
month = "3",
day = "1",
doi = "10.1124/mol.107.042606",
language = "English (US)",
volume = "73",
pages = "919--929",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - A novel high-throughput screening system identifies a small molecule repressive for matrix metalloproteinase-9 expression

AU - Nair, Rajesh R.

AU - Avila, Hector

AU - Ma, Xujun

AU - Wang, Zhengxin

AU - Lennartz, Michelle

AU - Darnay, Bryant G.

AU - Boyd, Douglas D.

AU - Yan, Chunhong

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Aberrant gene expression is one of the driving forces for cancer progression and is considered an ideal target for chemical intervention. Although emerging bioluminescence reporter systems allow high-throughput searches for small molecules regulatory for gene expression, frequent silencing of reporter genes by epigenetic mechanisms hinders wide application of this drug discovery strategy. Here we report a novel system that directs the integration of a promoter-reporter construct to an open chromosomal location by Flp-mediated homologous recombination, thereby overcoming reporter-gene silencing. Using this system, we have screened more than 8000 compounds in the DIVERSet chemical library for repressors of a matrix metalloproteinase-9 (MMP-9) promoter and identified 5-methyl-2-(4-methylphenyl)-1H-benzimidazole (MPBD) inhibitory for MMP-9 gene expression. Consistent with this effect, MPBD inhibits MMP-9-dependent invasion of UMSCC-1 oral cancer cells, preosteoclast migration, and receptor activator of nuclear factor-κB ligand-induced osteoclast activity over concentration ranges that repressed MMP-9 expression. Mechanistic studies indicated that MPBD antagonizes AP-1 function by inhibiting its transactivation activity. We conclude that the Flp-mediated homologous recombination system to direct reporter integration into open chromatin regions represents a novel strategy allowing for the development of high-throughput systems screening for lead compounds targeting aberrant gene expression in cancer.

AB - Aberrant gene expression is one of the driving forces for cancer progression and is considered an ideal target for chemical intervention. Although emerging bioluminescence reporter systems allow high-throughput searches for small molecules regulatory for gene expression, frequent silencing of reporter genes by epigenetic mechanisms hinders wide application of this drug discovery strategy. Here we report a novel system that directs the integration of a promoter-reporter construct to an open chromosomal location by Flp-mediated homologous recombination, thereby overcoming reporter-gene silencing. Using this system, we have screened more than 8000 compounds in the DIVERSet chemical library for repressors of a matrix metalloproteinase-9 (MMP-9) promoter and identified 5-methyl-2-(4-methylphenyl)-1H-benzimidazole (MPBD) inhibitory for MMP-9 gene expression. Consistent with this effect, MPBD inhibits MMP-9-dependent invasion of UMSCC-1 oral cancer cells, preosteoclast migration, and receptor activator of nuclear factor-κB ligand-induced osteoclast activity over concentration ranges that repressed MMP-9 expression. Mechanistic studies indicated that MPBD antagonizes AP-1 function by inhibiting its transactivation activity. We conclude that the Flp-mediated homologous recombination system to direct reporter integration into open chromatin regions represents a novel strategy allowing for the development of high-throughput systems screening for lead compounds targeting aberrant gene expression in cancer.

UR - http://www.scopus.com/inward/record.url?scp=40849124249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849124249&partnerID=8YFLogxK

U2 - 10.1124/mol.107.042606

DO - 10.1124/mol.107.042606

M3 - Article

C2 - 18065684

AN - SCOPUS:40849124249

VL - 73

SP - 919

EP - 929

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 3

ER -